CPBIO Holding Company Limited (HKG:3839)
Hong Kong · Delayed Price · Currency is HKD 8.80
+0.05 (0.57%)
Aug 27, 2026, 4:08 PM HKT
CPBIO Holding Company Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 423.98 | 535.91 | 307.75 | 173.98 | 159.24 | 142.41 | |
Revenue Growth | -18.95% | 74.14% | 76.89% | 9.26% | 11.82% | 52.18% |
Cost of Revenue | 353.59 | 458.48 | 258.81 | 143.79 | 120.05 | 107.65 |
Gross Profit | 70.38 | 77.44 | 48.93 | 30.19 | 39.19 | 34.76 |
Selling, General & Admin | 40.41 | 38.55 | 37.76 | 34.72 | 34.31 | 29.79 |
Operating Expenses | 40.41 | 38.55 | 37.76 | 34.72 | 34.31 | 29.79 |
Operating Income | 29.97 | 38.89 | 11.18 | -4.54 | 4.88 | 4.97 |
Interest Expense | -1.22 | -1.69 | -2.22 | -1.95 | -0.99 | -0.65 |
Interest & Investment Income | 0.95 | 0.93 | 1.39 | 1.15 | 0.37 | 0.08 |
Earnings From Equity Investments | 2.8 | 3.98 | 2.73 | 6.91 | -6.87 | 6.22 |
Currency Exchange Gain (Loss) | -0.87 | 0.69 | -0.24 | -0.3 | -1.62 | 0.22 |
Other Non Operating Income (Expenses) | 2.34 | 2.45 | 2.07 | 1.65 | 1.6 | 1.82 |
EBT Excluding Unusual Items | 33.95 | 45.24 | 14.92 | 2.91 | -2.64 | 12.66 |
Merger & Restructuring Charges | - | - | - | - | - | 18.61 |
Gain (Loss) on Sale of Assets | -0.43 | -0.97 | 1.14 | 0.03 | -0.11 | 0.06 |
Pretax Income | 33.52 | 44.27 | 16.05 | 2.94 | -2.75 | 31.33 |
Income Tax Expense | 6.43 | 7.34 | 2.13 | 1.06 | 1.51 | 4.63 |
Earnings From Continuing Operations | 27.09 | 36.93 | 13.92 | 1.89 | -4.26 | 26.7 |
Minority Interest in Earnings | -2.66 | -4.88 | -2.75 | 0.67 | -2.42 | -7.13 |
Net Income | 24.43 | 32.06 | 11.17 | 2.55 | -6.68 | 19.56 |
Net Income to Common | 24.43 | 32.06 | 11.17 | 2.55 | -6.68 | 19.56 |
Net Income Growth | -6.93% | 187.03% | 337.45% | - | - | 20.36% |
Shares Outstanding (Basic) | 253 | 253 | 253 | 253 | 253 | 253 |
Shares Outstanding (Diluted) | 253 | 253 | 253 | 253 | 253 | 253 |
Shares Change | - | - | - | - | - | - |
EPS (Basic) | 0.10 | 0.13 | 0.04 | 0.01 | -0.03 | 0.08 |
EPS (Diluted) | 0.10 | 0.13 | 0.04 | 0.01 | -0.03 | 0.08 |
EPS Growth | -6.93% | 187.03% | 337.47% | - | - | 20.36% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | - | 28.04 | -2.56 | -27.17 | -10.38 | -28.46 |
Free Cash Flow Per Share | - | 0.11 | -0.01 | -0.11 | -0.04 | -0.11 |
Gross Margin | 16.60% | 14.45% | 15.90% | 17.35% | 24.61% | 24.41% |
Operating Margin | 7.07% | 7.26% | 3.63% | -2.61% | 3.06% | 3.49% |
Profit Margin | 5.76% | 5.98% | 3.63% | 1.47% | -4.19% | 13.74% |
Free Cash Flow Margin | - | 5.23% | -0.83% | -15.62% | -6.52% | -19.99% |
EBITDA | 39.52 | 48.21 | 19.17 | 1.8 | 11.67 | 12.38 |
EBITDA Margin | 9.32% | 9.00% | 6.23% | 1.03% | 7.33% | 8.69% |
D&A For EBITDA | 9.56 | 9.32 | 7.99 | 6.34 | 6.79 | 7.41 |
EBIT | 29.97 | 38.89 | 11.18 | -4.54 | 4.88 | 4.97 |
EBIT Margin | 7.07% | 7.26% | 3.63% | -2.61% | 3.06% | 3.49% |
Effective Tax Rate | 19.17% | 16.57% | 13.30% | 35.92% | - | 14.78% |